Recombinant Human Erythropoietin iorEPOCIM® for the treatment of anemia in pediatric cancer patients
Recombinant human erythropoietin is widely used in the treatment of anemia due to cancer. A retrospective, longitudinal and descriptive study was conducted at the Jose Luis Miranda Provincial Pediatric University Hospital in Santa Clara, Villa Clara, to evaluate the impact and effectiveness of the u...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Editorial Ciencias Médicas
2011-10-01
|
| Series: | Acta Médica del Centro |
| Subjects: | |
| Online Access: | http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/663 |